Literature DB >> 7309778

CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.

D M Goldenberg, A M Neville, A C Carter, V L Go, E D Holyoke, K J Isselbacher, P S Schein, M Schwartz.   

Abstract

A consensus Development Conference was held at the National Institutes of Health from September 29-October 1, 1980, to address issues concerning the role of carcinoembryonic antigen (CEA) as a marker in the management of cancer. The panel met following formal presentations and discussions to assess the issues based on the evidence presented. These issues included: Should CEA be used in cancer screening? Is CEA helpful in cancer diagnosis? What does CEA tell about the extent and outcome of cancer? Is CEA helpful in monitoring cancer treatment? This paper constitutes the panel's findings.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7309778     DOI： 10.1007/bf00410109

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  13 in total

1.  Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding.

Authors:  R P Junghans; T A Waldmann
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

2.  Neutron-capture therapy of human cancer: in vivo results on tumor localization of boron-10-labeled antibodies to carcinoembryonic antigen in the GW-39 tumor model system.

Authors:  D M Goldenberg; R M Sharkey; F J Primus; E Mizusawa; M F Hawthorne
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

3.  Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.

Authors:  K A Chester; R H Begent
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

4.  Is tissue polypeptide antigen more accurate than serum CEA for diagnosing pancreatic cancer?

Authors:  A Panucci; C Fabris; G Del Favero; D Basso; F Di Mario; L Marchioro; A Piccoli; M Lise; A Burlina; R Naccarato
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

5.  A strategy for blood biomarker amplification and localization using ultrasound.

Authors:  Aloma L D'Souza; Jeffrey R Tseng; Kim Butts Pauly; Samira Guccione; Jarrett Rosenberg; Sanjiv S Gambhir; Gary M Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

Review 6.  Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics.

Authors:  Jieru E Lin; Michael Valentino; Glen Marszalowicz; Michael S Magee; Peng Li; Adam E Snook; Brian A Stoecker; Chang Chang; Scott A Waldman
Journal:  Toxins (Basel)       Date:  2010-08-05       Impact factor: 4.546

7.  Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA.

Authors:  S A Watson; T M Morris; H M Collins; L J Bawden; K Hawkins; E A Bone
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

8.  Knowledge discovery for pancreatic cancer using inductive logic programming.

Authors:  Yushan Qiu; Kazuaki Shimada; Nobuyoshi Hiraoka; Kensei Maeshiro; Wai-Ki Ching; Kiyoko F Aoki-Kinoshita; Koh Furuta
Journal:  IET Syst Biol       Date:  2014-08       Impact factor: 1.615

9.  Tumor characterization by ultrasound-release of multiple protein and microRNA biomarkers, preclinical and clinical evidence.

Authors:  Aloma L D'Souza; John R Chevillet; Pejman Ghanouni; Xinrui Yan; Muneesh Tewari; Sanjiv S Gambhir
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

10.  Clinical Value of CXCL5 for Determining of Colorectal Cancer

Authors:  Kadir Yildirim; Elif Colak; Recep Aktimur; Seda Gun; Mehmet Hakan Taskin; Adil Nigdelioglu; Sude Hatun Aktimur; Filiz Karagöz; Nuraydin Ozlem
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.